These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 4036430)
1. [Various quantitative characteristics of the pathoarchitectonics of the cerebral cortex in Pick disease and Alzheimer disease]. Preobrazhenskaia NS Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(7):969-73. PubMed ID: 4036430 [TBL] [Abstract][Full Text] [Related]
2. [Posterior cortical atrophy--a new dementia syndrome or a form of Alzheimer's disease?]. Pantel J; Schröder J Fortschr Neurol Psychiatr; 1996 Dec; 64(12):492-508. PubMed ID: 9053390 [TBL] [Abstract][Full Text] [Related]
4. [Cytoarchitectonic characteristics of the fields of the human cerebral cortex in Alzheimer's disease and senile dementia]. Bogolepova IN Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(7):39-44. PubMed ID: 3188773 [TBL] [Abstract][Full Text] [Related]
7. Topography of Pick body distribution in Pick's disease: a contribution to understanding the relationship between Pick's and Alzheimer's diseases. Yoshimura N Clin Neuropathol; 1989; 8(1):1-6. PubMed ID: 2539932 [TBL] [Abstract][Full Text] [Related]
8. [Relation between the degree of severity of the dementia and the extent of the manifestation of the pathomorphological changes in the cerebral cortex in senile dementia and Alzheimer's disease]. Shefer VF Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(7):1004-6. PubMed ID: 6475406 [TBL] [Abstract][Full Text] [Related]
9. Variations in cortical thickness with dementia severity in Alzheimer's disease. Im K; Lee JM; Seo SW; Yoon U; Kim ST; Kim YH; Kim SI; Na DL Neurosci Lett; 2008 May; 436(2):227-31. PubMed ID: 18400396 [TBL] [Abstract][Full Text] [Related]
10. Temporal cortex synaptophysin mRNA is reduced in Alzheimer's disease and is negatively correlated with the severity of dementia. Heffernan JM; Eastwood SL; Nagy Z; Sanders MW; McDonald B; Harrison PJ Exp Neurol; 1998 Apr; 150(2):235-9. PubMed ID: 9527892 [TBL] [Abstract][Full Text] [Related]
11. The limbic system in Alzheimer's disease. A neuropathologic investigation. Hopper MW; Vogel FS Am J Pathol; 1976 Oct; 85(1):1-20. PubMed ID: 135514 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the severity of neuropathologic changes in familial and sporadic Alzheimer's disease. Nochlin D; van Belle G; Bird TD; Sumi SM Alzheimer Dis Assoc Disord; 1993; 7(4):212-22. PubMed ID: 8305189 [TBL] [Abstract][Full Text] [Related]
13. [Clinico-pathological investigation of two patients with dementia with motor neuron disease]. Yamamoto R; Iseki E; Murayama N; Minegishi M; Kimura M; Eto K; Arai H; Ohbu S; Hatanaka D; Hino H; Fujisawa K Brain Nerve; 2007 Mar; 59(3):263-9. PubMed ID: 17370652 [TBL] [Abstract][Full Text] [Related]
14. Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease. Chan D; Fox NC; Scahill RI; Crum WR; Whitwell JL; Leschziner G; Rossor AM; Stevens JM; Cipolotti L; Rossor MN Ann Neurol; 2001 Apr; 49(4):433-42. PubMed ID: 11310620 [TBL] [Abstract][Full Text] [Related]
15. Comparing gray matter loss profiles between dementia with Lewy bodies and Alzheimer's disease using cortical pattern matching: diagnosis and gender effects. Ballmaier M; O'Brien JT; Burton EJ; Thompson PM; Rex DE; Narr KL; McKeith IG; DeLuca H; Toga AW Neuroimage; 2004 Sep; 23(1):325-35. PubMed ID: 15325380 [TBL] [Abstract][Full Text] [Related]
16. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292 [TBL] [Abstract][Full Text] [Related]
17. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies. Beyer MK; Larsen JP; Aarsland D Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706 [TBL] [Abstract][Full Text] [Related]
19. Dementia in Parkinson's disease: biochemical evidence for cortical involvement using the immunodetection of abnormal Tau proteins. Vermersch P; Delacourte A; Javoy-Agid F; Hauw JJ; Agid Y Ann Neurol; 1993 May; 33(5):445-50. PubMed ID: 8498822 [TBL] [Abstract][Full Text] [Related]